Filing Details
- Accession Number:
- 0000899243-21-025828
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-06-24 20:55:41
- Reporting Period:
- 2021-06-22
- Accepted Time:
- 2021-06-24 20:55:41
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1662244 | Cyteir Therapeutics Inc. | CYT | Pharmaceutical Preparations (2834) | 455429901 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1864377 | Janwillem Naesens | 128 Spring St, Building A, Suite 510 Lexington MA 02421 | No | No | Yes | No | |
1867855 | Sarl Gp Ii Df | 28 Boulevard Joseph Ii Luxembourg N4 L-1840 | No | No | Yes | No | |
1867886 | Luc Verelst | 28 Boulevard Joseph Ii Luxembourg N4 L-1840 | No | No | Yes | No | |
1867904 | Bv Wepaven | Brusselsesteenweg 11 Meise C9 1860 | No | No | Yes | No | |
1867968 | Scsp Ii Invest Droia | 28 Boulevard Joseph Ii Luxembourg N4 L-1840 | No | No | Yes | No | |
1868013 | Sa Ihl | 28 Boulevard Joseph Ii Luxembourg N4 L-1840 | No | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Acquisiton | 2021-06-22 | 3,259,026 | $0.00 | 3,259,026 | No | 4 | C | Direct | |
Common Stock | Acquisiton | 2021-06-22 | 277,777 | $18.00 | 3,536,803 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | C | Direct | |
No | 4 | P | Direct |
Reported Derivative Transactions
Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
---|---|---|---|---|---|---|---|
Common Stock | Series B Convertible Preferred Stock | Disposition | 2021-06-22 | 10,000,000 | $0.00 | 2,933,583 | $0.00 |
Common Stock | Series C Convertible Preferred Stock | Disposition | 2021-06-22 | 1,109,368 | $0.00 | 325,443 | $0.00 |
Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
---|---|---|---|---|---|---|
0 | No | 4 | C | Direct | ||
0 | No | 4 | C | Direct |
Footnotes
- Each share of Series B Convertible Preferred Stock and Series C Convertible Preferred Stock converted into shares of Common Stock at a ratio of 3.4088:1 upon completion of the Issuer's initial public offering. The shares have no expiration date.
- Shares held by Droia Invest II SCSp. DF II GP Sarl is the general partner of Droia Invest II SCSp. Wepaven BV (represented by Janwillem Naesens) and IHL SA (represented by Luc Verelst), the managers of DF II GP Sarl, share voting and investment power with respect to the shares held of record by Droia Invest II SCSp. Mr. Naesens, a member of the Issuer's board of directors, disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein. Luc Verelst disclaims beneficial ownership of the securities reported herein except to the extent of his pecuniary interest therein.